Brief: Kintara Therapeutics, Tuhura Biosciences Enter Into Merger Agreement

TuHURA Biosciences

03/04/2024 12:14

April 3 (Reuters) - Kintara Therapeutics Inc  KTRA.O :
    * KINTARA THERAPEUTICS AND TUHURA BIOSCIENCES ENTER INTO
DEFINITIVE MERGER AGREEMENT
    * KINTARA THERAPEUTICS INC - $31 MILLION SUBSCRIBED
FINANCING BY
TUHURA IN CONNECTION WITH MERGER AGREEMENT EXPECTED TO PROVIDE
CASH RUNWAY INTO LATE 2025
    * KINTARA THERAPEUTICS INC - COMBINED COMPANY IS EXPECTED TO
OPERATE UNDER NAME "TUHURA BIOSCIENCES, INC."
    * KINTARA THERAPEUTICS - ON A PRO FORMA BASIS, POST-MERGER
CO'S
EQUITYHOLDERS EXPECTED TO COLLECTIVELY OWN UP TO ABOUT 2.85%, OR
APPROXIMATELY 5.45%
    * KINTARA THERAPEUTICS INC - TUHURA EQUITYHOLDERS ARE
EXPECTED TO
COLLECTIVELY OWN APPROXIMATELY 97.15%, OR 94.55% ASSUMING
DISTRIBUTION OF CVR SHARES
    * KINTARA THERAPEUTICS INC -COMBINED COMPANY IS EXPECTED TO
TRADE
ON NASDAQ CAPITAL MARKET ("NASDAQ") UNDER TICKER "HURA"

Source text for Eikon:  ID:nPn1ySWk5a 
Further company coverage:  KTRA.O 

 ((Reuters.Briefs@thomsonreuters.com;))